tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

MRSN Stock Latest News

Promising Clinical Trial Data and Upcoming Presentations Bolster Buy Rating for Mersana Therapeutics
RatingsPromising Clinical Trial Data and Upcoming Presentations Bolster Buy Rating for Mersana Therapeutics
5d ago
MRSN
Promising Efficacy and Strategic Positioning of Mersana Therapeutics’ Emi-Le Drive Buy Rating
PremiumRatings
Promising Efficacy and Strategic Positioning of Mersana Therapeutics’ Emi-Le Drive Buy Rating
9d ago
MRSN
Mersana Therapeutics price target raised to $10 from $9 at Truist
PremiumThe Fly
Mersana Therapeutics price target raised to $10 from $9 at Truist
11d ago
MRSN
Mersana Therapeutics Reports Promising Clinical Advances
PremiumCompany Announcements
Mersana Therapeutics Reports Promising Clinical Advances
12d ago
MRSN
Mersana Therapeutics’ Earnings Call: Mixed Outlook with Clinical Gains
PremiumCompany Announcements
Mersana Therapeutics’ Earnings Call: Mixed Outlook with Clinical Gains
12d ago
MRSN
Positive Developments in Mersana Therapeutics’ TNBC Trials and Stable Financial Position Support Buy Rating
PremiumRatingsPositive Developments in Mersana Therapeutics’ TNBC Trials and Stable Financial Position Support Buy Rating
12d ago
MRSN
Promising Clinical Trial Results and Strategic Development Drive Buy Rating for Mersana Therapeutics
Premium
Ratings
Promising Clinical Trial Results and Strategic Development Drive Buy Rating for Mersana Therapeutics
12d ago
MRSN
Mersana Therapeutics reports Q1 EPS (19c), consensus (19c)
Premium
The Fly
Mersana Therapeutics reports Q1 EPS (19c), consensus (19c)
13d ago
MRSN
Mersana Therapeutics (MRSN) Q1 Earnings Cheat Sheet
PremiumPre-Earnings
Mersana Therapeutics (MRSN) Q1 Earnings Cheat Sheet
15d ago
MRSN
Strategic Restructuring and Focus on Emi-Le Drive Buy Rating for Mersana Therapeutics
PremiumRatings
Strategic Restructuring and Focus on Emi-Le Drive Buy Rating for Mersana Therapeutics
21d ago
MRSN
Mersana Therapeutics Announces Strategic Restructuring Plan
PremiumCompany Announcements
Mersana Therapeutics Announces Strategic Restructuring Plan
22d ago
8K
MRSN
Mersana Therapeutics implements restructuring plan, will reduce workforce by 55%
PremiumThe Fly
Mersana Therapeutics implements restructuring plan, will reduce workforce by 55%
22d ago
MRSN
Positive Outlook for Mersana Therapeutics Amid Strategic Developments and Financial Stability
PremiumRatingsPositive Outlook for Mersana Therapeutics Amid Strategic Developments and Financial Stability
3M ago
MRSN
Positive Outlook for Mersana Therapeutics: Buy Rating Backed by Promising Pipeline and Strong Financial Position
Premium
Ratings
Positive Outlook for Mersana Therapeutics: Buy Rating Backed by Promising Pipeline and Strong Financial Position
3M ago
MRSN
Mersana Therapeutics’ Viability in Question Amidst Persistent Financial Losses and Funding Challenges
Premium
Company Announcements
Mersana Therapeutics’ Viability in Question Amidst Persistent Financial Losses and Funding Challenges
3M ago
MRSN
Mersana Therapeutics Reports Progress and Financial Results
PremiumCompany Announcements
Mersana Therapeutics Reports Progress and Financial Results
3M ago
MRSN
Mersana Therapeutics’ Earnings Call Highlights Clinical Progress and Financial Gains
PremiumCompany Announcements
Mersana Therapeutics’ Earnings Call Highlights Clinical Progress and Financial Gains
3M ago
MRSN
Mersana Therapeutics: Strong Buy Rating Backed by Robust Financial Performance and Strategic Market Positioning
PremiumRatings
Mersana Therapeutics: Strong Buy Rating Backed by Robust Financial Performance and Strategic Market Positioning
3M ago
MRSN
Strategic Advancements and Competitive Positioning Bolster Buy Rating for Mersana Therapeutics
PremiumRatings
Strategic Advancements and Competitive Positioning Bolster Buy Rating for Mersana Therapeutics
3M ago
MRSN
Mersana Therapeutics Announces Positive Phase 1 Clinical Data
PremiumCompany AnnouncementsMersana Therapeutics Announces Positive Phase 1 Clinical Data
3M ago
8K
MRSN
Mersana Therapeutics reports Q4 EPS (11c), consensus (17c)
Premium
The Fly
Mersana Therapeutics reports Q4 EPS (11c), consensus (17c)
3M ago
MRSN
MRSN Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
MRSN Upcoming Earnings Report: What to Expect?
3M ago
MRSN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >